It was reported that the pressure was not increase on oxygenator, and an oxygenation problem occurred at 100% po2 70 mmhg.Customer changed the product and po2 increased over 300 mmhg.No harm or death to any person was reported.The sample was investigated at maquet cardiopulmonary gmbh laboratory on 2024-01-23.A visual control was performed for any kind of damages, deformations, cracks.There could not be found any damage on the oxygenator.The product was checked for clots, and there could not be found any clots on blood inlet neither on blood outlet of oxygenator.Further, blood side, water side and gas side were rinsed out with tap water, no clots were flushed out.Pressure increase was not observed.Tightness test of the blood side was passed successfully, there was no leakage detected during the test period of 6 hours.Integrity tightness tests of the blood- and of the gas side have passed.As per the laboratory results, there is no indication of any technical cause behind the insufficient oxygenation.Thus, the failure could not be reproduce and therefore could not be confirmed.The production history record (dhr) of the affected quadrox-i adult with lot # 3000335432 was reviewed on 2024-01-22.According to the dhr results, the product quadrox-i adult passed the defined manufacturing and final release specifications.There is no indication on manufacturing issues.Thus production related influences are unlikely.The production history record (dhr) of the affected vkmo 71000 with lot# 3000346027 was reviewed on 2023-12-07.According to the dhr result, the product vkmo 71000 passed the defined manufacturing and final release specifications.There is no indication on manufacturing issues.Thus production related influences are unlikely.Based on the investigation results, there could not be found any failure that is related with product and product¿s performance.The exact cause of the failure could not be determined.The occurrence rate was calculated for the reported failure and product and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
|